Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on exosome-based therapies, announces that it expects to enter into the rapidly growing telehealth market, following its agreement to acquire a telehealth company, which will serve as the foundation of a new division, Exousia Health. Completion of this acquisition is a key step in diversifying the company’s future revenue streams. Following the acquisition closing, Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. The telehealth company’s existing platform and patient roster would immediately contribute to the company’s financial performance.
Read the full article: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/exousia-pro-announces-strategic-acquisition-to-launch-a-new-telehealt-1070361